Improved health care utilization and costs in transplanted versus non-transplanted adults with sickle cell disease

• Published in: PloS one Vol. 15; no. 2; p. e0229710
• Main Authors: Saraf, Santosh L., Ghimire, Krishna, Patel, Pritesh, Sweiss, Karen, Gowhari, Michel, Molokie, Robert E., Gordeuk, Victor R., Rondelli, Damiano
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 26.02.2020; Public Library of Science (PLoS)
• Subjects: Adults; Antibodies; Biology and Life Sciences; Blood; Comparative analysis; Complications; Diseases; Economic aspects; Emergency medical care; Emergency medical services; Engineering and Technology; Erythrocytes; Health aspects; Health care; Health care costs; Health care expenditures; Health care policy; Health care reform; Health services utilization; Hematology; Hematopoietic stem cell transplantation; Hematopoietic stem cells; Hemoglobin; Histocompatibility antigen HLA; Hospital patients; Hospitals; Medical care quality; Medical care utilization; Medical economics; Medicine; Medicine and Health Sciences; Morbidity; Oncology; Patients; Pharmacy; Regression analysis; Sickle cell anemia; Sickle cell disease; Stem cell transplantation; Stem cells; Surgery; Therapy; Transplantation; Transplants & implants; Utilization; United States > US; Illinois; Chicago Illinois

Patients with sickle cell disease (SCD) have access to fewer health care resources and therapies compared to other diseases, which contributes to increased morbidity and health care utilization. We compared health care utilization (inpatient hospital days, emergency care visits) and health care-rela...